Please ensure Javascript is enabled for purposes of website accessibility

Why ResMed Stock Is Shooting Higher Today

By Brian Feroldi - Updated Oct 25, 2019 at 11:27AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares hit an all-time high after the medical device maker posts strong quarterly results.

What happened

After management reported fiscal 2020 first-quarter results, shares of ResMed (RMD 0.06%), a medical device maker focused on sleep-disorder breathing, rose 12% as of 12:00 p.m. EDT on Friday.

So what

The headline numbers from the period were great:

  • Revenue jumped 16% to $681 million. This figure handily beat the consensus estimate on Wall Street of $661 million.
  • Net income grew 14% to $120 million, or $0.83 per share.
  • Non-GAAP net income per share rose 15% to $0.93. This was $0.06 above what market watchers had forecasted.

Traders sent the share price to a new all-time high in response to the upbeat quarterly results.

Man sleeping with CPAP machine on face.

Image source: Getty Images.

Now what

CEO Mick Farrell stated that the upbeat quarterly performance positions the company well to deliver on its long-term objectives:

Through organic growth and targeted acquisitions, we're driving forward every facet of our business, leading the innovation of devices and software that improve health outcomes, create efficiencies, and reduce overall healthcare system costs. We're well on our way to improving 250 million lives in out-of-hospital healthcare in 2025.

Overall, this report shows that ResMed is more than capable of growing its revenue and profits at a double-digit clip. With plenty of runway ahead of it, I continue to believe that ResMed is a great healthcare stock for growth-focused investors to get to know.

Brian Feroldi has no position in any of the stocks mentioned. The Motley Fool recommends ResMed. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ResMed Inc. Stock Quote
ResMed Inc.
$236.78 (0.06%) $0.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/10/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.